These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 37680157)
1. The Power of Molecular Dynamics Simulations and Their Applications to Discover Cysteine Protease Inhibitors. Dos Santos Nascimento IJ; Gomes JNS; de Oliveira Viana J; de Medeiros E Silva YMS; Barbosa EG; de Moura RO Mini Rev Med Chem; 2024; 24(11):1125-1146. PubMed ID: 37680157 [TBL] [Abstract][Full Text] [Related]
2. Discovery and characterization of trypanocidal cysteine protease inhibitors from the 'malaria box'. Pereira GAN; da Silva EB; Braga SFP; Leite PG; Martins LC; Vieira RP; Soh WT; Villela FS; Costa FMR; Ray D; de Andrade SF; Brandstetter H; Oliveira RB; Caffrey CR; Machado FS; Ferreira RS Eur J Med Chem; 2019 Oct; 179():765-778. PubMed ID: 31284086 [TBL] [Abstract][Full Text] [Related]
4. Drug Discovery Efforts to Identify Novel Treatments for Neglected Tropical Diseases - Cysteine Protease Inhibitors. Giroud M; Kuhn B; Haap W Curr Med Chem; 2024; 31(16):2170-2194. PubMed ID: 37916489 [TBL] [Abstract][Full Text] [Related]
5. Molecular docking of potential SARS-CoV-2 papain-like protease inhibitors. Li D; Luan J; Zhang L Biochem Biophys Res Commun; 2021 Jan; 538():72-79. PubMed ID: 33276953 [TBL] [Abstract][Full Text] [Related]
6. Quantum mechanics/molecular mechanics studies of the mechanism of cysteine protease inhibition by peptidyl-2,3-epoxyketones. Arafet K; Ferrer S; González FV; Moliner V Phys Chem Chem Phys; 2017 May; 19(20):12740-12748. PubMed ID: 28480929 [TBL] [Abstract][Full Text] [Related]
7. Computer-aided design of 1,4-naphthoquinone-based inhibitors targeting cruzain and rhodesain cysteine proteases. Silva LR; Guimarães AS; do Nascimento J; do Santos Nascimento IJ; da Silva EB; McKerrow JH; Cardoso SH; da Silva-Júnior EF Bioorg Med Chem; 2021 Jul; 41():116213. PubMed ID: 33992862 [TBL] [Abstract][Full Text] [Related]
8. Discovery of Novel Inhibitors of Cruzain Cysteine Protease of Prates JLB; Lopes JR; Chin CM; Ferreira EI; Dos Santos JL; Scarim CB Curr Med Chem; 2024; 31(16):2285-2308. PubMed ID: 37888814 [TBL] [Abstract][Full Text] [Related]
9. First quantum mechanics/molecular mechanics studies of the inhibition mechanism of cruzain by peptidyl halomethyl ketones. Arafet K; Ferrer S; Moliner V Biochemistry; 2015 Jun; 54(21):3381-91. PubMed ID: 25965914 [TBL] [Abstract][Full Text] [Related]
10. Experimental study and computational modelling of cruzain cysteine protease inhibition by dipeptidyl nitriles. Dos Santos AM; Cianni L; De Vita D; Rosini F; Leitão A; Laughton CA; Lameira J; Montanari CA Phys Chem Chem Phys; 2018 Sep; 20(37):24317-24328. PubMed ID: 30211406 [TBL] [Abstract][Full Text] [Related]
11. Self-Masked Aldehyde Inhibitors: A Novel Strategy for Inhibiting Cysteine Proteases. Li L; Chenna BC; Yang KS; Cole TR; Goodall ZT; Giardini M; Moghadamchargari Z; Hernandez EA; Gomez J; Calvet CM; Bernatchez JA; Mellott DM; Zhu J; Rademacher A; Thomas D; Blankenship LR; Drelich A; Laganowsky A; Tseng CK; Liu WR; Wand AJ; Cruz-Reyes J; Siqueira-Neto JL; Meek TD J Med Chem; 2021 Aug; 64(15):11267-11287. PubMed ID: 34288674 [TBL] [Abstract][Full Text] [Related]
12. Elucidating the Dual Mode of Action of Dipeptidyl Enoates in the Inhibition of Rhodesain Cysteine Proteases. Arafet K; González FV; Moliner V Chemistry; 2021 Jul; 27(39):10142-10150. PubMed ID: 33852187 [TBL] [Abstract][Full Text] [Related]
13. The impact of whole genome sequence data on drug discovery--a malaria case study. Joachimiak MP; Chang C; Rosenthal PJ; Cohen FE Mol Med; 2001 Oct; 7(10):698-710. PubMed ID: 11713369 [TBL] [Abstract][Full Text] [Related]
14. Benzimidazole inhibitors of the major cysteine protease of Pereira GA; Santos LH; Wang SC; Martins LC; Villela FS; Liao W; Dessoy MA; Dias LC; Andricopulo AD; Costa MA; Nagem RA; Caffrey CR; Liedl KR; Caffarena ER; Ferreira RS Future Med Chem; 2019 Jul; 11(13):1537-1551. PubMed ID: 31469332 [No Abstract] [Full Text] [Related]
15. α-ketoheterocycles as inhibitors of Leishmania mexicana cysteine protease CPB. Steert K; Berg M; Mottram JC; Westrop GD; Coombs GH; Cos P; Maes L; Joossens J; Van der Veken P; Haemers A; Augustyns K ChemMedChem; 2010 Oct; 5(10):1734-48. PubMed ID: 20799311 [TBL] [Abstract][Full Text] [Related]
16. Targeting cysteine proteases in trypanosomatid disease drug discovery. Ferreira LG; Andricopulo AD Pharmacol Ther; 2017 Dec; 180():49-61. PubMed ID: 28579388 [TBL] [Abstract][Full Text] [Related]
17. Use of cysteine-reactive small molecules in drug discovery for trypanosomal disease. Nicoll-Griffith DA Expert Opin Drug Discov; 2012 Apr; 7(4):353-66. PubMed ID: 22458506 [TBL] [Abstract][Full Text] [Related]
18. Targeting Cysteine Proteases and their Inhibitors to Combat Trypanosomiasis. Saha A; Pushpa ; Moitra S; Basak D; Brahma S; Mondal D; Molla SH; Samadder A; Nandi S Curr Med Chem; 2024; 31(16):2135-2169. PubMed ID: 37340748 [TBL] [Abstract][Full Text] [Related]
19. A structure-based virtual high-throughput screening, molecular docking, molecular dynamics and MM/PBSA study identified novel putative drug-like dual inhibitors of trypanosomal cruzain and rhodesain cysteine proteases. Eurtivong C; Zimmer C; Schirmeister T; Butkinaree C; Saruengkhanphasit R; Niwetmarin W; Ruchirawat S; Bhambra AS Mol Divers; 2024 Apr; 28(2):531-551. PubMed ID: 36617352 [TBL] [Abstract][Full Text] [Related]
20. Toward the discovery of inhibitors of babesipain-1, a Babesia bigemina cysteine protease: in vitro evaluation, homology modeling and molecular docking studies. Pérez B; Antunes S; Gonçalves LM; Domingos A; Gomes JR; Gomes P; Teixeira C J Comput Aided Mol Des; 2013 Sep; 27(9):823-35. PubMed ID: 24129820 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]